Walleye Capital
BIIB icon

Walleye Capital’s Biogen BIIB Stock Holding History

Walleye Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.49M Sell
13,600
-31,300
-70% -$5.77M 0.01% 1294
2025
Q4 		$7.9M Buy
44,900
+27,800
+163% +$4.54M 0.02% 806
2025
Q3 		$2.4M Sell
17,100
-13,200
-44% -$1.78M 0.01% 1448
2025
Q2 		$3.81M Sell
30,300
-100
-0.3% -$12.5K 0.01% 1054
2025
Q1 		$4.16M Buy
30,400
+23,100
+316% +$3.3M 0.02% 904
2024
Q4 		$1.12M Buy
7,300
+900
+14% +$152K ﹤0.01% 2289
2024
Q3 		$1.24M Sell
6,400
-12,300
-66% -$2.57M ﹤0.01% 2410
2024
Q2 		$4.34M Sell
18,700
-47,100
-72% -$10.2M 0.01% 1393
2024
Q1 		$14.2M Buy
65,800
+50,900
+342% +$11.9M 0.03% 604
2023
Q4 		$3.86M Buy
14,900
+5,800
+64% +$1.42M 0.01% 1275
2023
Q3 		$2.34M Buy
9,100
+5,100
+128% +$1.36M 0.01% 1615
2023
Q2 		$1.14M Buy
4,000
+300
+8% +$89.3K ﹤0.01% 1747
2023
Q1 		$1.03M Buy
3,700
+1,400
+61% +$387K 0.02% 1153
2022
Q4 		$637K Buy
+2,300
New +$650K 0.01% 1302
2020
Q2 		– Sell
-900
Closed -$285K – 625
2020
Q1 		$285K Sell
900
-8,200
-90% -$2.49M 0.06% 358
2019
Q4 		$2.7M Sell
9,100
-20,400
-69% -$5.66M 0.18% 137
2019
Q3 		$6.87M Buy
29,500
+13,600
+86% +$3.17M 0.41% 31
2019
Q2 		$3.72M Buy
15,900
+14,900
+1,490% +$3.44M 0.41% 23
2019
Q1 		$236K Buy
+1,000
New +$315K 0.04% 699

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Capital's BIIB Position: Q1 2026 in Review

Walleye Capital increased its Biogen (BIIB) stake by 2,144% in Q1 2026, buying an estimated $6.22M and bringing the position to 35,339 shares worth $6.48M. The position accounts for 0.03% of the portfolio, ranked #635.

Walleye Capital first reported a position in BIIB in Q3 2018 and has held it in 19 quarters since. The position peaked at $11M in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Walleye Capital held 35,339 shares of Biogen worth $6.48M as of Q1 2026.
  • Walleye Capital bought 33,764 Biogen shares in Q1 2026, an estimated $6.22M.
  • Biogen made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #635 holding.
  • Walleye Capital first reported a position in Biogen in Q3 2018 and has held it in 19 quarters since.
  • Walleye Capital's Biogen position peaked at $11M in Q2 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.